DR. ARUNA AREKAPUDI, MD

NEW SMYRNA BEACH, FL

Research Active
Internal Medicine - Medical Oncology NPI registered 21+ years 4 publications 2015 – 2023 NPI: 1811992852
PrognosisPostoperative ComplicationsBiomarkersCanadaNeutrophilsModels, StatisticalKetamineDepressionOutcome Assessment, Health CareDepressive Disorder, Treatment-ResistantPerioperative PeriodInfusions, IntravenousLymphocyte CountBorderline Personality DisorderCardiovascular Surgical Procedures

Practice Location

401 PALMETTO ST
NEW SMYRNA BEACH, FL 32168-7322

Phone: (386) 424-5038

What does ARUNA AREKAPUDI research?

Dr. Arekapudi studies the effectiveness of ketamine infusions in treating young adults and individuals with both treatment-resistant depression and borderline personality disorder. She aims to provide effective alternatives for those who have not responded to conventional treatments. Additionally, she researches the neutrophil-lymphocyte ratio (NLR), a blood measurement that can indicate inflammation, and its implications for patients undergoing surgery, helping to identify those at higher risk for complications.

Key findings

  • In a study of young adults aged 18-25 with treatment-resistant depression, after four ketamine infusions, there was a significant reduction in depression symptoms and suicidal thoughts, with p-values less than 0.001.
  • Patients with borderline personality disorder receiving ketamine showed a nearly 6-point reduction in depression scores and a 0.64-point decrease in borderline symptoms.
  • In a study of over 1,100 patients pre-surgery, 26.6% had high neutrophil-lymphocyte ratios, indicating inflammation linked to higher surgery risk.
  • A systematic review of nearly 3,500 patients found that a neutrophil-lymphocyte ratio above 3.3 for heart surgery was associated with more than an 80% increased risk of mortality over 35 months.

Frequently asked questions

Does Dr. Arekapudi study treatment-resistant depression?
Yes, Dr. Arekapudi focuses on the effectiveness of ketamine infusions for treating treatment-resistant depression in young adults and those with borderline personality disorder.
What treatments has Dr. Arekapudi researched?
She has researched the use of repeated intravenous ketamine infusions as a treatment option for individuals with treatment-resistant depression.
Is Dr. Arekapudi's work relevant to patients undergoing surgery?
Yes, her research on the neutrophil-lymphocyte ratio helps identify patients at risk for complications during and after surgery.

Publications in plain English

Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder.

2023

Psychiatry research

Danayan K, Chisamore N, Rodrigues NB, Vincenzo JDD, Meshkat S +11 more

Plain English
This study looked at how effective repeated doses of ketamine are for people with treatment-resistant depression (TRD) who also have borderline personality disorder (BPD). Researchers found that both groups—those with BPD and those without—saw significant improvements in their depression and anxiety symptoms after receiving ketamine, with the BPD group experiencing a notable reduction in depression scores by nearly 6 points and borderline symptoms by 0.64 points. This is important because it shows that ketamine can be an effective treatment option for a challenging combination of mental health issues. Who this helps: This helps patients struggling with treatment-resistant depression and borderline personality disorder.

PubMed

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth.

2023

Journal of psychopharmacology (Oxford, England)

Chisamore N, Danayan K, Rodrigues NB, Di Vincenzo JD, Meshkat S +10 more

Plain English
This study looked at how effective repeated ketamine infusions are for young adults aged 18 to 25 who have treatment-resistant depression. The researchers found that after four infusions over two weeks, these young patients showed significant improvement in their depression and anxiety symptoms, as measured by standard questionnaires. Specifically, there was a major reduction in overall depression symptoms and suicidal thoughts, with p-values less than 0.001, indicating strong results. Importantly, the safety and side effects were similar for these youths and older adults, meaning ketamine works well for both groups. Who this helps: This benefits young adults suffering from severe depression who haven't responded to other treatments.

PubMed

Neutrophil-lymphocyte ratio as predictor of mortality and morbidity in cardiovascular surgery: a systematic review.

2015

ANZ journal of surgery

Tan TP, Arekapudi A, Metha J, Prasad A, Venkatraghavan L

Plain English
This study looked at the neutrophil-lymphocyte ratio (NLR), which is a measure of inflammation in the body, to see if it could predict complications and death in patients undergoing heart and blood vessel surgeries. The analysis included data from five studies with nearly 3,500 patients and found that a higher NLR before surgery (above 3.3 for heart surgery and above 5 for vascular surgery) was linked to a more than 80% higher risk of death over an average follow-up period of about 35 months. Understanding NLR can help doctors better assess the risks for patients and manage their care before and after surgery. Who this helps: This helps patients undergoing cardiovascular surgery and their doctors in planning for better outcomes.

PubMed

Neutrophil Lymphocyte Ratio as a predictor of systemic inflammation - A cross-sectional study in a pre-admission setting.

2015

F1000Research

Venkatraghavan L, Tan TP, Mehta J, Arekapudi A, Govindarajulu A +1 more

Plain English
This study looked at a blood measurement called the neutrophil-lymphocyte ratio (NLR) in over 1,100 patients before surgery, finding that 26.6% had high NLR levels, which can indicate inflammation. High NLR levels were linked to serious health issues like heart failure and cancer, and were also associated with higher anesthesia risk scores. Understanding NLR's role helps doctors assess surgery risks more accurately. Who this helps: This helps patients and doctors by identifying those at higher risk for complications before surgery.

PubMed

Frequent Co-Authors

Noah Chisamore Kevork Danayan Nelson B Rodrigues Joshua D Di Vincenzo Shakila Meshkat Zoe Doyle Rodrigo Mansur Lee Phan Farhan Fancy Edmond Chau

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.